• HOME PAGE
  • ABOUT US
  • OUR TEAM
    • Doctors
    • Nurses
    • Laboratory Technicians
    • Public Relations
    • Support Staff
  • OUR SERVICES
    • Cancer Diagnosis and Treatment
    • Laboratory Services
    • Nursing Services
  • ARTICLES
    • New Developments in Cancer Treatment
    • New Developments in Lung Cancer Treatment
    • New Developments in Early-Stage Breast Cancer Treatment
    • New Developments in the Treatment of Metastatic Breast Cancer
    • New Developments in Colon Cancer Treatment
    • New Developments in Pancreatic Cancer Treatment
    • New Developments in Prostate Cancer Treatment
  • TANSAN IN THE PRESS
  • EVENTS & DEVELOPMENTS
  • VIDEOS
  • CONTACT
+90 212 225 27 56
  • Home
  • Blog
  • News
  • Immunotherapy

BLOG

0
February 2, 2018, Friday / Published in News

Immunotherapy

We used to think that the immune system wasn't very important in cancer, except for one or two types. Now we understand that this isn't the case. Our soldier cells that fight cancer, T cells, or T lymphocytes, don't function very well under sadness and high stress; they become sluggish and dull. In fact, cancer cells form in our bodies every day, but our T lymphocytes recognize them, saying, "Come here, you naughty thing!" and eat them. When T lymphocytes become sluggish and unable to recognize and attack cancer cells, those cancer cells grow, multiply, create their own blood vessels, and become actual cancer. Now, the newest approach in oncology is to activate these T cells more against cancer. For this purpose, 5 immunotherapy drugs (pembrolizumab, nivolumab, atezolizumab, durvalumab, avelumab) are currently widely used in various types of cancer. With these drugs, both the chance of a response to treatment increases and we see very long survival times.

Dr. Süalp Tansan

  • Tweet

What you can read next

New Developments in Cancer Treatment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Call

Latest News & Announcements

  • Tansan Oncology Celebrates its 30th Anniversary with Pride.

    As Tansan Oncology, we are a passenger in the field of healthcare...
  • Following the Path of Scientific Progress: Participation of Our Clinical Team in the Turkish Medical Oncology Congress 2026

    Closely following the latest developments in the field of oncology...
  • We need to stop fighting death.

    Click to go to the link. He turned his pocket...
  • Müjdat Gezen wrote: Süalp Tansan | Cumhuriyet

    Click here to go to the link. Kandemir (Kond...
  • ‘'Vitamin D plays a vital role in preventing cancer!'’

    Click here to go to the link. Dr. Sualp Tansa...
  • LAW ON THE PROTECTION OF PERSONAL DATA (LPPD) INFORMATION TEXT
  • PERSONAL DATA STORAGE AND DESTRUCTION POLICY
  • POLICY ON THE PROTECTION AND PROCESSING OF SPECIAL CATEGORY PERSONAL DATA
  • DECLARATION OF EXPLICIT CONSENT UNDER THE PERSONAL DATA PROTECTION LAW (KVKK)
  • SATISFACTION SURVEY

Tansan Oncology © 03.07.2026 All rights reserved.
These articles are written for patient information purposes.

TOP
EN
TR
By continuing to use our website, our privacy policy By doing so, you agree to the use of cookies.